GASTROINTESTINAL AND OTHER SELECTED ADVERSE EFFECTS OF CYCLIN-DEPENDENT KINASE 4 AND 6 INHIBITORS IN BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Shohdy, Kyrillus [2 ]
Lasheen, Shaimaa [2 ]
Kassem, Loay [2 ]
Abdel-Rahman, Omar [1 ]
机构：
[1] Ain Shams Fac Med, Dept Clin Oncol, Cairo, Egypt
[2] Kasr Alainy Sch Med, Dept Clin Oncol, Cairo, Egypt
来源：
BREAST | 2017年 / 36卷
关键词：
D O I：
10.1016/S0960-9776(17)30719-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO100
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2-Breast Cancer: A Systematic Review and Meta-Analysis
    Hong, Kai
    Yao, Lingli
    Sheng, Xianneng
    Ye, Dan
    Guo, Yu
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (10) : 557 - 567
  • [32] Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review
    Zhao, Melody
    Hanson, Kent A.
    Zhang, Yixie
    Zhou, Anna
    Cha-Silva, Ashley S.
    TARGETED ONCOLOGY, 2023, 18 (03) : 327 - 358
  • [33] Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Preclinical and Clinical Data
    Vidula, Neelima
    Rugo, Hope S.
    CLINICAL BREAST CANCER, 2016, 16 (01) : 8 - 17
  • [34] Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review
    Melody Zhao
    Kent A. Hanson
    Yixie Zhang
    Anna Zhou
    Ashley S. Cha-Silva
    Targeted Oncology, 2023, 18 : 327 - 358
  • [35] Oral adverse effects of CDK4/6 inhibitors among breast cancer patients: a systematic review and meta-analysis
    Long, Quanyi
    Li, Xiaomin
    Wu, Gonghua
    Zhang, Jia
    Li, Hongjiang
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (06) : 6556 - 6563
  • [36] Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
    Dorota Kwapisz
    Breast Cancer Research and Treatment, 2017, 166 : 41 - 54
  • [37] Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
    Micha, John P.
    Rettenmaier, Mark A.
    Bohart, Randy D.
    Goldstein, Bram H.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (03) : 547 - 551
  • [38] Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
    Kwapisz, Dorota
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 41 - 54
  • [39] Overall survival with cyclin-dependent kinase 4/6 inhibitors plus endocrine therapy in breast cancer: A meta-analysis of randomized controlled trials
    Tian, Q.
    Yang, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S366 - S366
  • [40] Cyclin-dependent kinase 4/6 inhibitor in combination with endocrine therapy versus endocrine therapy only for advanced breast cancer: a systematic review and meta-analysis
    Xu, Zhi-Hong
    Zhang, Heng
    Wei, Deng-Hui
    Xie, Li-Li
    Xu, Chun-Sen
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (02) : 657 - 668
12345